Amoebic Meningitis: Current Challenges and Emerging Threats with Special Focus on the Kerala Experience

Abstract

Free-living amoebae are the source of amoebic meningitis, one of the most deadly infectious disorders that damage the central nervous system, such as Balamuthia mandrillaris, Acanthamoeba species, and Naegleria fowleri. This illness includes granulomatous amoebic encephalitis (GAE) and primary amoebic meningoencephalitis (PAM), both of which have fatality rates that are higher than 95%. Even though these infections are uncommon, growing numbers of cases have drawn attention from all around the world, especially in tropical areas like Kerala, India, where large outbreaks have happened. This review highlights the urgent need for prevention-focused public health initiatives and cutting-edge treatment approaches while synthesizing current information in the areas of epidemiology, pathophysiology, clinical symptoms, diagnostic techniques, and therapeutic approaches.

Keywords

Introduction

Free-living amoebae have become powerful opportunistic pathogens that can cause fatal infections of the central nervous system. These amphizoic organisms are a distinct class of pathogens that defy accepted theories about the transmission and management of infectious diseases because they can live independently in environmental reservoirs while parasitizing human hosts (1). Since amoebic meningitis is one of the most deadly illnesses known to medicine, with fatality rates that routinely surpass those of the majority of bacterial and viral infections, its clinical relevance goes well beyond its rarity.

The two clinical entities that are included under the name "amoebic meningitis" differ greatly in terms of their pathophysiology, causative organisms, and clinical course. Naegleria fowleri, a thermophilic amoeba that has gained the sinister nickname "brain-eating amoeba" because of its capacity to induce a fast, necrotizing brain infection, is the primary cause of primary amoebic meningoencephalitis (PAM) (2). On the other hand, infections with Acanthamoeba species and Balamuthia mandrillaris, which usually cause more chronic but equally deadly illnesses, induce granulomatous amoebic encephalitis (GAE) (3).Microscopic image of Naegleria fowleri trophozoite (Fig:1) and Primary amoebic meningoencephalitis (Fig: 2) on CNS has shown.

Figure 1- Naegleria fowleri trophozoite: CSF cytospin sediment stained with Wright-Giemsa, 1000x magnification . CDC, public domain image.(R3)

Figure 2- Primary amoebic meningoencephalitis: Extensive exudate and hemorrhage of the frontal cerebral cortex. CDC, public domain image21.

The increasing global recognition of these infections reflects not only improved diagnostic capabilities and clinical awareness but also genuine increases in disease incidence driven by climate change, expanding recreational water activities, and urbanization patterns that bring humans into closer contact with contaminated water sources. In tropical and subtropical areas, where warm temperatures foster amoebic growth and exposure risks are increased by recreational and cultural water behaviors, this development is especially noticeable.

Historical Findings and the Development of Knowledge Fowler and Carter's seminal study in Adelaide, Australia, in 1965, which established Naegleria fowleri as the causal agent of primary amoebic meningoencephalitis, marked the beginning of the modern understanding of amoebic meningitis (3). In their first study, they detailed four cases—three involving infants and one involving an adult—whose autopsy findings demonstrated the distinct pathophysiological process by which amoebae use olfactory nerve routes to migrate to the central nervous system. In addition to starting decades of research into the epidemiology, etiology, and management of these illnesses, this discovery laid the groundwork for our current understanding of them.

Retrospective examination of pathological specimens kept in the Pathological Museum in London, for example, showed cases from April 1909 that had histological features typical of amoebic infection, indicating that these illnesses were present long before they were officially recognized (3). The necessity of clinical attention and appropriate diagnoses is highlighted by the fact that many past occurrences of "idiopathic" acute meningoencephalitis were probably unidentified amoebic infections. Global case accumulation and developments in molecular techniques since the initial report by Fowler and Carter have enhanced amoebic meningitis's detection, epidemiological precision, and comprehension as a global health issue.

Global Epidemiology and Distribution Patterns:

With instances documented from 39 nations on every inhabited continent, the global distribution of amoebic meningitis illustrates the pervasiveness of free-living amoebae in freshwater habitats (1,12). A total of 381 instances were reported worldwide between 1962 and 2018, although this number probably indicates a considerable underreporting because of diagnostic constraints, a lack of clinical awareness, and insufficient monitoring systems in many areas (1). Since many cases may be misdiagnosed as bacterial or viral meningitis, especially in places with limited resources and molecular diagnostic skills, the exact worldwide prevalence of these infections is yet unknown.

The majority of the 146 cases documented in the United areas by 2022 came from southern areas where exposure risk is increased by warm weather and recreational water use (12). The majority happen during the summer and are associated with freshwater activities like swimming, diving, and using pools that aren't properly chlorinated.
Pakistan recorded 154 instances between 2008 and 2023, posing a serious public health risk in South Asia (12). Poor water treatment, cultural traditions, contaminated water use, and climate conditions that favor amoebic growth are all factors contributing to this high occurrence. In Mexico, Australia, and the Czech Republic, among other severely impacted nations, case clustering illustrates the interplay among human behavior, environmental factors, and the detection capabilities of the healthcare system.

Emerging Patterns in India and the Kerala Experience:

With 26 recorded infections between 1962 and 2018, India has shown a significant rise in recognized PAM cases over the previous 20 years (12). However, given that more cases have been identified recently due to advancements in diagnostic technology and clinical awareness, this number probably represents significant underreporting. The geographical distribution of Indian cases reveals a concentration in southern regions, especially Kerala, where water usage habits and environmental factors produce high-risk situations.

THE KERALA OUTBREAK: A CASE STUDY IN EMERGING DISEASE

After a string of cases, starting with the first confirmed case of PAM in March 2016, Kerala state has become a crucial target for amoebic meningitis research and public health action. A 16-year-old boy from the Alappuzha district was the subject of this index case. He had the typical symptoms of a high fever, neck rigidity, severe frontal headache, prolonged vomiting, excessive sleepiness with altered sensorium, and irrelevant speech episodes (2). The case was the first laboratory-confirmed PAM case in the state and sparked increased surveillance efforts that exposed the full scope of the issue, making it a turning point in Indian infectious disease surveillance. Eight confirmed PAM cases were found in various districts of Kerala as a result of subsequent monitoring efforts; the geographic distribution of these cases includes two from each of the districts of Alappuzha and Thrissur, three from Malappuram, and one from Kozhikode (2). Instead of confined point-source exposure, this distribution pattern revealed widespread environmental contamination, suggesting that N. fowleri can proliferate in a variety of climatic and geographic zones throughout the state. Kerala. Eight PAMs in all were confirmed.

Thus far, Kerala has recorded two cases from Alappuzha, two from Thrissur, three from Malappuram, and one from Kozhikode district (Fig. 3). (2)

Figure 3-.District-wise Confirmed Primary Amoebic Meningoencephalitis Cases Reported in Kerala [2]

Figure 4;-. (A) Shows high environmental temperature favoring conversion of cystic forms of free-living amoeba (FLA) into pathogenic trophozoite forms. (B) Mode of infection by Naegleria fowleri. Accidental entry of contaminated water high up in the nose enables the parasite to ascend and spread to the brain via cribriform plate (B1). Brain develops acute inflammatory lesion and causes death in PAM. ^[5]

VIRULENCE FACTORS AND PATHOGENIC MECHANISMS

The pathogenicity of these amoebae arises from multiple virulence factors enabling host invasion, survival, and tissue damage. N. fowleri uses contact-dependent mechanisms, adhering to host cells via surface proteins such as integrin-like molecules, fibronectin-binding proteins, and protein kinase C-mediated interactions and phagocytosing neurons through specialized feeding structures called amoebastomes (10).

Key molecular virulence factors of N. fowleri include Nfa1 (promotes locomotion and feeding structure formation), Nf-actin (enhances adhesion, phagocytosis, and cytotoxicity), Mp2CL5 (mediates cell recognition and adhesion), and cytoskeletal proteins like Rho-GEF, myosins, and villin-1 that support tissue invasion and motility (10). Proteolytic enzymes, such as matrix metalloproteinases (MMP-2, MMP-9, and MMP-14), cysteine proteases that break down tight junctions and the blood-brain barrier, and pore-forming proteins that cause cellular lysis, are secreted by contact-independent mechanisms.

Pathophysiology of Disease:

1. Primary Amoebic Meningoencephalitis Development:

N. fowleri trophozoites, which target the olfactory epithelium, bind via receptor-ligand interactions, and migrate along olfactory nerves through the cribriform plate to the olfactory bulb, spreading into brain tissue, are the first step in the pathophysiology of PAM (10). Rapid neurological degeneration results from this direct invasion of the central nervous system, which circumvents systemic immune responses. Through feeding processes, N. fowleri destroys tissue within the central nervous system (CNS) and produces severe inflammation, which leads to cerebral edema, elevated intracranial pressure, hemorrhagic necrosis of the frontal and temporal lobes, and brain herniation.

B. Granulomatous Amoebic Encephalitis Progression:

GAE takes weeks to months to develop, which is slower than PAM. Acanthamoeba and Balamuthia cause chronic granulomatous inflammation with multinucleated giant cells, persistent inflammatory infiltrates, and progressive tissue damage. They can enter through inhalation, skin wounds, or hematogenous dissemination (6). Long-term persistence is made possible by their cyst stage, which also permits latent organisms to reawaken, which adds to the chronic, relapsing course and complicates therapy results.

Host Immune Responses and Disease Progression:

A double-edged sword, the host immune response to amoebic infection contributes to tissue damage and the advancement of disease while also offering some protection against infection. Innate immune systems such as complement activation, neutrophil recruitment, and the generation of pro-inflammatory cytokines, especially IL-1β, IL-8, and TNF-α, are activated in the initial reaction (7). These reactions, however, are insufficient to manage amoebic infections and may worsen tissue damage by causing excessive inflammation.
Remarkably, antibodies (IgA, IgG) do not stop the course of PAM, and the majority of patients are immunocompetent (10). While N. fowleri escapes complement-mediated death by internalizing and eliminating membrane attack complexes, allowing survival in spite of humoral immunity, rapid tissue penetration surpasses adaptive immune responses.

CLINICAL PRESENTATIONS AND DISEASE COURSE

1. Primary Amoebic Meningoencephalitis Manifestations:

PAM is a severe, quickly developing meningoencephalitis that frequently leads to a misdiagnosis because it first looks like bacterial meningitis. The brief incubation period, which ranges from 24 hours to 7 days and typically occurs 5–7 days following water exposure (2,14), reflects the direct CNS invasion of N. fowleri. Severe frontal headache, elevated fever, nausea, vomiting, and stiff neck are examples of early nonspecific symptoms (2). Confusion, behavioral abnormalities, lack of coordination, hallucinations, seizures, and coma are all signs of neurological decline that advances quickly (17). Although some patients survive up to 18 days with intensive care, death usually happens 4–11 days after onset.

2. Granulomatous Amoebic Encephalitis Features:

Because GAE develops gradually over weeks to months, it is frequently mistaken for brain tumors, persistent infections, or neurodegenerative disorders (3). Chronic headaches, cognitive deterioration, personality changes, and focal deficits depending on the location of the lesion are examples of subacute neurological symptoms that patients present with. In contrast to PAM, GAE can cause space-occupying lesions on imaging, which may indicate neoplasms. It can also cause progressive paralysis, visual or speech abnormalities, and late-stage seizures that are indicative of granulomatous inflammation.

DIAGNOSTIC CHALLENGES AND CLINICAL MIMICRY

Since PAM closely resembles bacterial meningitis in terms of fever, headache, neck stiffness, and impaired mental status, amoebic meningitis presents significant diagnostic issues. Low glucose, increased protein, and neutrocytic pleocytosis are CSF findings that are similar to bacterial infections (14,15). Detailed exposure histories, particularly recent freshwater contact, are crucial for generating clinical suspicion and directing prompt diagnosis because the rarity of cases causes delayed detection.

Diagnostic Approaches and Laboratory Methods:

1. Traditional Diagnostic Techniques:

Finding viable amoebae in clinical specimens—typically CSF obtained by lumbar puncture—is necessary for the conclusive diagnosis of amoebic meningitis. Within minutes, motile trophozoites can be seen through wet mount analysis of fresh, warm CSF (9). The motility of Acanthamoeba is slower than that of N. fowleri, which travels quickly and has noticeable pseudopodia. Trophozoites among inflammatory cells can be identified by CSF cytology using stains such Giemsa, Wright, or trichrome; however, precise identification necessitates skilled staff to prevent confusion with macrophages or other cells.

When brain tissue is available, histopathological analysis shows organisms in tissue sections, which is conclusive proof of amoebic infection. While immunohistochemical methods employing certain antibodies can offer species-level identification and confirmation of pathogenic organisms, special stains such as periodic acid-Schiff (PAS) and silver stains can highlight amoebic structures and make identification easier.

2. Advanced Molecular Diagnostics:

Amoebic infection detection has been revolutionized by contemporary molecular diagnostics, which provide quick, accurate, and precise identification. Amoebic DNA in CSF, tissues, and ambient materials can be found using PCR techniques, such as nested and pan-FLA PCR, which are as accurate as classical microscopy but produce results in a matter of hours (10). When conventional testing yield negative results, next-generation sequencing (NGS) allows for the simultaneous detection of numerous diseases. Real-time PCR methods provide quantitative information on organism load and enable quick, species-specific detection. New point-of-care molecular assays promise better patient outcomes and quicker diagnosis.

3. Immunological and Serological Approaches:

Using antibodies against species-specific antigens, immunohistochemistry (IHC) and indirect immunofluorescence (IIF) allow for the precise identification of amoebae in tissue and CSF; IHC is particularly helpful for formalin-fixed tissues where motility cannot be evaluated (1). Because of the quick course of the disease and the absence of protective immunity, serological testing is not very useful for acute diagnosis. However, it can provide epidemiological information and identify previous subclinical exposures; better serological assays are still being researched.

D. Emerging Diagnostic Technologies:

The detection of amoebic infections is being improved by emerging diagnostic methods. Rapid identification using protein profiles is made possible by MALDI-TOF mass spectrometry, and point-of-care applications in resource-constrained environments may be possible using biosensors and microfluidic devices. In order to improve accuracy and consistency and lessen reliance on specialized parasitology knowledge, artificial intelligence and machine learning are being used to support microscopic identification.

CURRENT TREATMENT STRATEGIES AND OUTCOMES

1. Standard Therapeutic Protocols:

Because amoebic meningitis infections are rare, the majority of treatment is empirical and based on case reports, in vitro data, and animal research. Aggressive combination regimens delivered intrathecally and systemically are the foundation of PAM therapy (10,15). Intravenous and intrathecal amphotericin B continue to be the mainstay, with liposomal versions being favored for their superior CNS penetration and lower toxicity. Because of their CNS activity, azole antifungals (fluconazole, voriconazole, and itraconazole) are added; they are frequently taken in combination with rifampicin. Miltefosine's in vitro effectiveness and survivor instances have demonstrated its potential as an adjuvant.

2. Adjunctive and Supportive Care Measures:

Intensive supportive care is part of the management of amoebic meningitis in addition to antibiotics. Although their effectiveness is questionable, corticosteroids such as dexamethasone are frequently used to lessen cerebral edema (10). Using osmotic agents, hyperventilation, or surgical decompression as necessary is essential for maintaining intracranial pressure control. To prevent medication interactions, seizures necessitate careful anticonvulsant selection. In addition, dietary assistance, hydration and electrolyte management, and secondary infection prevention are all part of comprehensive treatment, which calls for multidisciplinary teams and significant medical resources because of the extended ICU stays.

3. Treatment Outcomes and Survival Patterns:

Survival in amoebic meningitis remains extremely poor. Less than 20 survivors have been reported globally, and PAM mortality is around 97% (1,10). Very early detection, timely combination antibiotic medication, and extensive supportive care in specialized facilities are usually beneficial to survivors. For best results, therapy should be started 24–48 hours after the onset of symptoms (7). With a 95% mortality rate, GAE outcomes are similarly dismal; survivors frequently experience long-lasting neurological impairments such cognitive impairment, motor dysfunction, and seizures, which reflects the chronic, incapacitating nature of the illness.

4. Novel and Experimental Therapeutic Approaches:

Research into new approaches to treating amoebic meningitis has been prompted by the shortcomings of existing treatments. Although there is little evidence of their effectiveness, immunomodulatory strategies like interferon-gamma and immunoglobulin seek to strengthen host defenses while reducing detrimental inflammation. Drug delivery methods based on liposomes and nanoparticles may lessen systemic toxicity and increase CNS penetration. Potential anti-amoebic drugs have been found through medication repurposing initiatives and evolving combination therapies that are guided by amoebic biology and susceptibility patterns, although there is currently a lack of clinical confirmation.

PREVENTION STRATEGIES AND PUBLIC HEALTH MEASURES

1. Primary Prevention Approaches:

Prevention is the best course of action because amoebic meningitis has a high fatality rate and few available treatments. Education, behavioral modifications, and environmental interventions are the main strategies used to reduce exposure to tainted water (4,12). Along with routine water quality monitoring, it is crucial to maintain adequate pH balance and chlorination (1–3 ppm) in swimming pools and recreational waterways. High-risk sports, such as diving, jumping, or swimming underwater in warm waters with strong nasal water input, should be avoided or at least lessened with the use of protective gear like nose clips.

2. Personal Protective Measures:

Preventing amoebic infections during aquatic sports requires individual precautions. When swimming or diving, nose clips can stop nasal water entry, and methods that reduce exposure should be emphasized in swimming instruction. Using sterile, distilled, or adequately boiled water is crucial in areas where ritual nose rinsing is practiced, and irrigation equipment should be cleansed and disinfected on a regular basis (2). Parents of children, residents and visitors in high-risk locations, and anyone practicing cultural or religious nasal activities should all receive education from healthcare experts regarding safer water contact and preventive actions.

3. Environmental and Community-Level Interventions:

Coordinated efforts by public health officials, environmental organizations, and healthcare systems are necessary for community-level prevention. Frequent recreational water monitoring can help identify high-risk locations and initiate remediation measures like improved treatment or temporary closures. Materials in local languages should be disseminated through community channels as part of public education programs that emphasize the dangers of water temperature fluctuations, proper pool care, and early symptom assessment using culturally relevant messaging. Supported by facility-specific water safety strategies, healthcare facilities should keep an eye on their water systems, including cooling towers, hot water tanks, and ornamental elements, to prevent nosocomial amoebic infections (8).

4. Climate Change Adaptation Strategies:

Since rising global temperatures increase the geographic and temporal ranges where amoebic organisms can thrive and cause disease, climate change poses a new challenge for preventing amoebic infections (5,16). Previously low-risk areas may be impacted by shifting risk patterns and environmental variables, which adaptation methods must take into consideration.

CONCLUSION

Due to tainted water supplies and shifting weather patterns, amoebic meningitis has lately become a public health concern in Kerala, the subject of this study. We talked about the difficulties in the area, such as early symptom detection, transmission routes, preventative measures, and available treatments. Early identification is essential since, if left untreated, the illness can quickly become lethal. To lower risk, preventive actions such using safe water practices, staying out of warm freshwater lakes, and increasing public awareness are crucial. Outbreaks can also be avoided by establishing water quality monitoring systems, teaching communities about personal hygiene, and bolstering the healthcare system for prompt diagnosis. To fight this fatal infection, more research into efficient treatments and better early detection techniques is still crucial.

ACKNOWLEDGMENTS

Through case reporting, innovative diagnostics, and clinical research, healthcare professionals, researchers, and public health officials from all across the world have helped us better understand amoebic meningitis. The authors thank them for their contributions.

CONFLICT OF INTEREST

Regarding the information in the manuscript, the authors affirm that none of them have any conflicts of interest with any private, public, or academic parties.

REFERENCES

1. 1. Gharpure R, et al. Epidemiology of primary amoebic meningoencephalitis (PAM): global trends, case classification, and diagnostic advances. Emerg Infect Dis. 2025;31(2):234-45.
   2. Regu K, et al. First reported PAM cases in Kerala: clinical features, seasonal trends, and public health implications. Indian J Med Microbiol. 2024;42(3):156-63.
   3. Gompf SG, et al. Historical perspective on PAM and GAE: emergence and pathogenesis of free-living amoebae. Clin Microbiol Rev. 2019;32(4):e00087-18.
   4. Baig AM, et al. Impact of climate change on free-living amoebae: public health implications and preventive strategies. Environ Health Perspect. 2019;127(4):047001.
   5. Kurup SB. Naegleria fowleri: clinical manifestations, pathophysiology, and treatment options. Curr Opin Infect Dis. 2021;34(3):225-32.
   6. Puthanpurayil SNT, et al. Case reports of PAM and Acanthamoeba GAE in India: diagnostic challenges and outcomes. Indian J Pediatr. 2023;90(8):789-95.
   7. Zamzuri MAIA, et al. Clinical course and immune response in PAM: importance of early diagnosis. J Neuroinfect Dis. 2023;15(2):78-85.
   8. Khurana S, et al. Isolation of free-living amoebae from hospital water systems: implications for infection control. Infect Control Hosp Epidemiol. 2015;36(8):946-52.
   9. Khurana S, et al. PCR-based detection of FLA in suspected CNS infections: diagnostic accuracy and clinical utility. J Clin Microbiol. 2022;60(5):e02841-21.
   10. Güémez A, García E. Therapeutic challenges and experimental approaches in PAM: a review. Expert Rev Anti Infect Ther. 2021;19(12):1547-55.
   11. Mittal N, et al. Case report of PAM in an infant: diagnostic and therapeutic challenges. Pediatr Infect Dis J. 2020;39(8):e234-7.
   12. Saha R, et al. Environmental drivers of PAM in India: epidemiology, detection, and control measures. Trop Med Int Health. 2025;30(1):45-54.
   13. Gajula SN, et al. Genomic, immunological, and proteomic insights into Naegleria fowleri pathogenesis. PLoS Pathog. 2023;19(7):e1011456.
   14. Suseela KV, et al. Clinical mimicry of bacterial meningitis in PAM: case study from Thrissur, India. J Assoc Physicians India. 2021;69(4):78-82.
   15. McLaughlin A, O’Gorman T. Primary amoebic meningoencephalitis: clinical presentation and treatment experience from Australia. Med J Aust. 2019;211(7):320-5.
   16. Stahl LM, et al. Ecology of Naegleria fowleri: environmental factors, climate change, and risk prediction models. Appl Environ Microbiol. 2020;86(15):e00740-20.
   17. Centers for Disease Control and Prevention. Naegleria fowleri – primary amebic meningoencephalitis (PAM). [Internet]. Atlanta (GA): CDC; [cited 2025 Jan]. Available from: [https://www.cdc.gov/parasites/naegleria/] (https://www.cdc.gov/parasites/naegleria/)